Trump's Proposed Tariffs on Pharmaceuticals Could Impact Drug Prices

Want the full story?
Read the complete article at KVIA
AI Summary
President Trump is set to introduce new tariffs on pharmaceutical imports, specifically targeting companies that have not agreed to sell their drugs directly to consumers under his 'Most Favored Nation' pricing initiative. The proposed tariffs would impose a 100% levy on patented drugs and their active ingredients, although companies could negotiate to reduce or avoid these tariffs by reaching agreements or relocating production to the U.S. The draft order is expected to be finalized and announced soon, potentially affecting drug prices for consumers. Critics within the GOP express concerns that these tariffs could lead to higher costs for Americans.
Key Details: • New tariffs expected to be announced Thursday afternoon. • 100% tariff on patented drugs unless companies negotiate deals. • Companies can reduce tariffs to 20% for four years by moving production to the U.S. • Tariff rates could revert to 100% in 2030 if no agreements are reached.